GT Biopharma Inc. Common Stock
$7.435
USD
Last updated on --.
24h volume5.00
24h highest7.4900 USD
24h lowest7.4900 USD
24h Price movement-0.73%
GTBP recent prices
24 Hours
-0.73%-$0.055
30 days
+3.66%+$0.2625
60 days
-12.79%-$1.090
90 days
-29.42%-$3.780
Key data
Previous close7.4900 USD
Market cap15.54M USD
Volume5.00
P/E ratio--
Dividend yield (TTM)0.01%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-30.9400 USD
Net income (FY)-45.68M USD
Revenue (FY)0.00 USD
Last report dateMar 2, 2026
About GT Biopharma Inc. Common Stock
HeadquartersSAN FRANCISCO
Employees (FY)1.00
Revenue per employee (FY)0.00 USD
Net income per employee (FY)-45.68M USD
Listed onNasdaq
GTBP conversion tables
 |  |
|---|---|
| 0.5 GTBP | 3.717 USD |
| 1 GTBP | 7.435 USD |
| 5 GTBP | 37.17 USD |
| 10 GTBP | 74.35 USD |
| |
|---|---|
| 0.5 USD | 0.067249 GTBP |
| 1 USD | 0.1345 GTBP |
| 5 USD | 0.67249 GTBP |
| 10 USD | 1.344 GTBP |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
GTBP is trading at $7.435, -0.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GTBP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GTBP is currently trading at $7.435, -0.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GTBP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GTBP's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GTBP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GTBP's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
GT Biopharma Inc. Common Stock's market cap is currently 15.54M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume5.00
24h highest7.4900 USD
24h lowest7.4900 USD
24h Price movement-0.73%
Start trade with GTBP Perpetual
Sign up to trade